Schedule 13G ownership disclosure

Syndax Pharmaceuticals Inc

Security class unavailable · CUSIP: 87164F105

Event date: 2021-04-20

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-21-003048
Form type
SC 13G/A
Filer
Avidity Partners Management LP
CIK
CIK 1791827
Filed
Apr 20, 2021
Reporting period
Apr 20, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub